搜索结果81-90 的 7693 / √ yeotop6 . com √●트위터추가●신풍동오피✡신풍동풀싸롱▲신풍동건마Ⅹ신풍동출장✆신풍동오피♀신풍동스파Ⅱ신풍동키스방

  1. 神经科- 临床试验- 妙佑医疗国际

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...

  2. 神经科- 临床试验- 妙佑医疗国际

    Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

  3. 神经科- 临床试验- 妙佑医疗国际

    Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

  4. 神经科- 临床试验- 妙佑医疗国际

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...

  5. 神经科- 临床试验- 妙佑医疗国际

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...

  6. 神经科- 临床试验- 妙佑医疗国际

    Scottsdale/Phoenix, Ariz. The main objective of the Brain Tumor Repository is to allow access to coded patient data by researchers both inside and outside of ...

  7. 神经科- 临床试验- 妙佑医疗国际

    Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

  8. 神经科- 临床试验- 妙佑医疗国际

    Rochester, Minn., Jacksonville, Fla. This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating ...

  9. 神经科- 临床试验- 妙佑医疗国际

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may ...

  10. 神经科- 临床试验- 妙佑医疗国际

    To establish a repository of DNA samples collected prospectively from patients with inherited myopathies of unknown molecular and/or biochemical defect.